Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 10Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibroma, Plexiform 1Metastatic Solid Tumors. 1Melanoma 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Gastrointestinal Stromal Tumors 1Dermoid Cyst 1Burkitt Lymphoma 1Blast Crisis 1

Interventions

Cytarabine 25Azacitidine 17fludarabine phosphate 15fludarabine 15Cyclophosphamide 14venetoclax 8Peripheral Blood Stem Cell Transplantation 8Methotrexate 8Busulfan 8Granulocyte Colony-Stimulating Factor 7Filgrastim 7Whole-Body Irradiation 6Decitabine 6Cyclosporine 6Injections 5Idarubicin 5decitabine and cedazuridine drug combination 4Tacrolimus 4Radiotherapy 4Mycophenolic Acid 4Mitoxantrone 4Daunorubicin 4Cladribine 4CPX-351 4Biopsy 4midostaurin 3merphos 3magrolimab 3gilteritinib 3Stem Cell Transplantation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myeloid, Acute × Imatinib Mesylate × Clear all
NCT00594555 2008-10-31

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

University of Cincinnati

Phase 2 Withdrawn
20 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Hematologic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡